3 completed, 1 terminated, 1 withdrawn. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 2, Terminated 1, Withdrawn 1 |
| Phase 1 | 1 | Completed 1 |
Follow BMS-823778: new trials by email Literature Review of BMS-823778 trials Research Report on BMS-823778
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Proof of Concept Study of BMS-823778 to Assess the Effects on Atherosclerosis BMS-823778, Placebo matching with BMS-823778 - Atherosclerotic Cardiovascular Disease | Phase 2 | Withdrawn | Bristol-Myers Squibb | 2014-04-01 | 2013-06-21 | |
| Safety and Efficacy Study of BMS-823778 to Treat Uncontrolled High Blood Pressure in Overweight and Obese Patients BMS-823778, Placebo matching with BMS-823778 - Hypertension | Phase 2 | Terminated | Bristol-Myers Squibb | 7 | 2012-07-01 | 2015-10-12 |
| Japanese Phase 1 Multiple Ascending Dose Study BMS-823778, Placebo matching with BMS-823778 - Type 2 Diabetes Mellitus | Phase 1 | Completed | Bristol-Myers Squibb | 40 | 2012-03-01 | 2012-12-05 |
| Safety Study of BMS-823778 in Subjects With Type 2 Diabetes BMS-823778, Placebo, Metformin - Diabetes Mellitus, Type 2 | Phase 2 | Completed | Bristol-Myers Squibb | 62 | 2010-07-01 | 2015-10-12 |
| Safety Study of BMS-823778 in Subjects With Hypercholesterolemia BMS-823778, Placebo - Dyslipidemia | Phase 2 | Completed | Bristol-Myers Squibb | 60 | 2010-06-01 | 2015-10-12 |
Diabetes Mellitus, Type 2 (2) · Atherosclerosis (1) · Dyslipidemias (1) · Hypertension (1)
United States (3) · Australia (2) · Canada (2) · Colombia (1) · Hungary (1) · Japan (1) · Puerto Rico (1) · Sweden (1)